Feedback / Questions
GPR65 agonist - OMass Therap
https://www.globenewswire.com/news-release/2022/04/28/2430921/0/en/OMass-Therapeutics-Raises-100-Million-in-Series-B-Financing-to-Progress-Drug-Pipeline-in-Immunology-and-Rare-Diseases.html
Apr 28, 2022
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious